Sharechat Logo

NZ pork lobby loses appeal over imported raw meat risk

Monday 18th March 2013

Text too small?

NZ Pork, the lobby group for the nation's pig farmers, has lost its appeal against changes to import health standards that will allow raw meat from countries with Porcine Reproductive and Respiratory Syndrome (PRRS) into New Zealand.

The disease, also known as blue-ear pig disease, causes still-born piglets and respiratory illnesses in young pigs. It costs the US swine industry more than US$600 million a year, according to the nationalhogfarmer.com website.

NZ Pork had challenged the Ministry of Primary Industries' response to an independent review panel report on raw meat imports which led to the ministry's decision to issue four new health standards for raw pork.

The new standards are less restrictive than those that have applied since 2001 but MPI director-general Wayne McNee says he is confident they effectively manage the risks of diseases such as PRRS becoming established in New Zealand.

He said under the new standards raw pork may only be imported without further treatment in consumer-ready cuts of less than 3 kilograms, free from lymphatic tissue.

According to NZ Pork, a total of 41,384 tonnes of pork was imported in 2011/2012, of which 97.5 percent was frozen. Canada was the biggest supplier, followed by the US, Finland and Australia.

Total domestic production of pork for 2011/12 was 49,787, down 0.6 percent from 2010/11.

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors